Cordis Corporation Research & Development – Product Pipeline

For 50 years, Cordis has been a pioneer in the development of breakthrough new products to help patients with cardiac and vascular conditions. Today, the company is exploring new advancements through a robust pipeline of near term and long-term potential products.

Cordis currently has new research and development projects in superficial femoral artery (SFA) disease, a closure device following an interventional procedure and AAA (abdominal aortic aneurysm), one of the top 15 leading causes of death.